🔗 Share this article

Chancellor Rachel Reeves has stated she is preparing "focused measures to address household expense challenges" in the upcoming Budget.

Speaking to media outlets, she emphasized that reducing price rises is a collective responsibility of both the administration and the Bank of England.

The United Kingdom's inflation rate is forecast to be the most elevated among the Group of Seven industrialized countries this calendar year and next.

Potential Utility Cost Interventions

Reports indicate the administration could take action to lower utility costs, such as by reducing the current 5% level of VAT charged on energy.

Another approach is to reduce some of the government charges currently included in household expenses.

Fiscal Limitations and Analyst Expectations

The government will receive the next draft from the independent fiscal watchdog, the Office for Budget Responsibility, on Monday, which will clarify how much scope there is for such measures.

The consensus from the majority of economists is that the Chancellor will have to announce tax increases or expenditure reductions in order to fulfill her declared borrowing rules.

Previously on the same day, analysis suggested there was a twenty-two billion pound deficit for the chancellor to fill, which is at the lower end of expectations.

"It is a joint task between the central bank and the administration to bear down further on some of the causes of price increases," the Chancellor told reporters in the US capital, at the annual meetings of the IMF and World Bank.

Tax Pledges and Global Concerns

While much of the focus has been on expected tax rises, the Treasury chief said the most recent information from the fiscal watchdog had not changed her pledge to manifesto promises not to raise rates on income tax, sales tax or social security contributions.

She blamed an "uncertain global environment" with increasing geopolitical and commercial concerns for the Budget revenue measures, probably to be focused on those "wealthiest."

International Trade Disputes

Referring to concerns about the UK's trade ties with China she said: "Our national security invariably come first."

Last week's statement by Chinese authorities to strengthen trade restrictions on rare earths and other materials that are key for advanced tech manufacturing led US President Donald Trump to suggest an additional 100% tariff on imports from China, increasing the risk of an full-scale commercial conflict between the two global powers.

The American finance chief described the Chinese decision "commercial pressure" and "a global supply chain control attempt."

Inquired about accepting the American proposal to join its battle with China, the Chancellor said she was "very concerned" by China's measures and encouraged the Beijing authorities "to avoid restrictions and limit trade."

She said the move was "bad for the international commerce and creates further challenges."

"In my view there are areas where we need to address Chinese policies, but there are also significant chances to export to Chinese markets, including financial services and other areas of the economic system. We've got to achieve that equilibrium correct."

The chancellor also confirmed she was working with G7 counterparts "on our own essential resources plan, so that we are more independent."

NHS Drug Pricing and Funding

Reeves also recognized that the cost the NHS pays for medicines could rise as a result of current discussions with the Trump administration and its drugs companies, in return for lower tariffs and capital.

Some of the biggest global drug companies have said in recent statements that they are either delaying or scrapping projects in the United Kingdom, with some blaming the insufficient payments they are receiving.

Last month, the Science Minister said the price the NHS spends on drugs would need to increase to prevent businesses and pharmaceutical investment departing from the United Kingdom.

The Chancellor informed media: "We have seen as a result of the cost structure, that drug testing, new drugs have not been available in the United Kingdom in the extent that they are in other European countries."

"Our aim is to guarantee that people receiving treatment from the National Health Service are able to receive the top essential drugs in the world. And so we are reviewing these issues, and... looking to secure increased capital into the UK."